NexImmune Long Term Debt Current 2011-2026 | NEXI

Annual Long Term Debt Current NexImmune

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
68.8 K	599 K	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
599 K	68.8 K	334 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	4.64 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	271 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	181 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	554 K	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA
Allena Pharmaceuticals ALNA	317 K	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	756 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
Aravive ARAV	2.2 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	193 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
AstraZeneca PLC AZN	382 M	-	-	$ 96.9 B	Britain
AVROBIO AVRO	878 K	-	1083.1 %	$ 745 M	USA
Axcella Health AXLA	1.59 M	-	-16.42 %	$ 249 M	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	20.7 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	21.2 M	-	-	$ 546 M	USA
Allakos ALLK	3.25 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	49 K	-	-5.38 %	$ 6.06 M	USA
Atreca BCEL	3.54 M	-	-11.76 %	$ 5.79 M	USA
CASI Pharmaceuticals CASI	1.06 M	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	274 K	-	-11.43 %	$ 502 K	USA
ChemoCentryx CCXI	2.81 M	-	-	$ 3.74 B	USA
AlloVir ALVR	316 K	-	4.14 %	$ 49.1 M	USA
Bellerophon Therapeutics BLPH	203 K	-	-74.18 %	$ 955 K	USA
Chimerix CMRX	642 K	-	-	$ 756 M	USA
AbbVie ABBV	194 M	$ 208.7	-0.07 %	$ 369 B	USA
Calithera Biosciences CALA	1.37 M	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	116 K	-	-3.03 %	$ 260 M	USA
AbCellera Biologics ABCL	5.82 M	$ 3.52	-0.14 %	$ 1.05 B	Canada